Percutaneous coronary intervention of unprotected left main coronary artery in the emergent/urgent setting

Area of Science:

• Interventional Cardiology
• Cardiovascular Surgery
• Acute Myocardial Infarction Management

Background:

• Percutaneous intervention for unprotected left main coronary disease is not an approved indication, even in urgent cases.
• Advancements in transcatheter technology and skilled operators in high-volume centers have enabled treatment of these complex cases.
• The study addresses the growing need to evaluate less invasive options for critical coronary conditions.

Purpose of the Study:

• To investigate the viability of percutaneous coronary intervention (PCI) as an alternative to coronary artery bypass graft (CABG) surgery for unprotected left main coronary disease in urgent settings.
• To compare the safety and efficacy of PCI versus CABG in this high-risk patient population.

Main Methods:

• A cohort of 51 patients with acute myocardial infarction and unprotected left main disease underwent PCI.
• This PCI cohort was compared to a matched group of 35 patients who underwent CABG surgery.
• Outcomes, including major adverse cardiac and cerebrovascular events (MACCE), were assessed in-hospital and at 30 days, 6 months, and 1 year.

Main Results:

• The estimated MACCE-free survival at 1 year post-PCI was 88%, with an overall MACCE rate of 6%.
• The CABG cohort experienced a higher overall MACCE rate of 17%.
• Predictors of MACCE in the Cox model included the Parsonnet score (surgical risk) and diabetes mellitus.

Conclusions:

• Percutaneous coronary intervention for unprotected left main coronary disease in urgent clinical settings is feasible.
• PCI demonstrates a relatively low short- and long-term rate of MACCE in this patient group.
• PCI may represent a viable alternative to CABG for selected patients with unprotected left main disease requiring urgent intervention.